Buten Matthew's Insider Trades & SAST Disclosures
Buten Matthew's most recent trade in Biohaven Ltd was a trade of 104,000 Stock Options (Right to buy) done . Disclosure was reported to the exchange on Jan. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Buten Matthew.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2025 | 104,000 | 104,000 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2025 | 17,000 | 17,000 | - | - | Restricted Share Unit Award | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2025 | 4,250 | 12,750 | - | - | Restricted Share Unit Award | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2025 | 4,250 | 196,013 | - | 0 | Common Shares | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.64 per share. | 05 Jan 2025 | 2,561 | 193,452 | - | 38.6 | 98,957 | Common Shares |
| Biohaven Ltd | Buten Matthew | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 96,250 | 96,250 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2023 | 78,750 | 78,750 | - | - | Stock Options (Right to buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 22.00 per share. | 05 Oct 2023 | 22,727 | 189,380 | - | 22 | 499,994 | Common Shares |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.50 per share. | 25 Oct 2022 | 142,857 | 166,653 | - | 10.5 | 1,499,999 | Common Shares |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 300,000 | 300,000 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 18,750 | 21,838 | - | 0 | Common Shares | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 11,450 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 11,450 | 11,450 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 03 Oct 2022 | 11,450 | 34,838 | - | 6.4 | 72,937 | Common Shares |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 03 Oct 2022 | 11,042 | 23,796 | - | 7.5 | 82,815 | Common Shares |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 3,088 | 3,088 | - | 0 | Common Shares | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 1,550 | 0 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2022 | 1,550 | 1,550 | - | - | Stock Options (Right to Buy) | |
| Biohaven Ltd | Matthew Buten | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.37 per share. | 03 Oct 2022 | 1,550 | 23,388 | - | 6.4 | 9,874 | Common Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges